Get started
Author

Sezgi Kaçar

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
2022 · Ingrid Anne Lie, Sezgi Kaçar, et al. · Journal of Neurology Neurosurgery & Psychiatry · 19
PDF
Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations
2024 · Eline ME Coerver, Sezgi Kaçar, et al. · Multiple Sclerosis Journal · 15
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis
2026 · Sezgi Kaçar, David R van Nederpelt, et al. · Journal of Neurology Neurosurgery & Psychiatry · 5
Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study
2023 · Sezgi Kaçar, Danko Coric, et al. · Brain Sciences · 1
PDF
Aging does not affect the relationship between OCT and clinical or MRI outcome measures
2026 · S. Kaçar, Julia R. Jelgerhuis, et al. · Multiple Sclerosis and Related Disorders
Towards Understanding Disease Progression in Multiple Sclerosis
2026 · Sezgi Kaçar
OCT and Multiple Sclerosis
2025 · Sezgi Kaçar, Eva M. M. Strijbis, et al. · Springer eBooks
Works count: 7
Citation count: 40
H-index: 3
I10-index: 2
Year
Topic
Type